about
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome.1H NMR detects different metabolic profiles in glioblastoma stem-like cells.A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.(1)H-MRS can detect aberrant glycosylation in tumour cells: a study of the HeLa cell line.Glycosidic intermediates identified in 1H MR spectra of intact tumour cells may contribute to the clarification of aspects of glycosylation pathways.Metabolic Study of Breast MCF-7 Tumor Spheroids after Gamma Irradiation by (1)H NMR Spectroscopy and Microimaging.Characterization of 1H NMR detectable mobile lipids in cells from human adenocarcinomas.Identification of amide protons of glutathione in MR spectra of tumour cells.Role of glutathione in apoptosis induced by radiation as determined by 1H MR spectra of cultured tumor cells.Metabolism of glutathione in tumour cells as evidenced by 1H MRS.1H MRS signals from glutathione may act as predictive markers of apoptosis in irradiated tumour cells.Optical images of dose distributions in Gel-Fricke: dosimetric performances of the gel.(1H) MRS studies of signals from mobile lipids and from lipid metabolites: comparison of the behavior in cultured tumor cells and in spheroids.Radionuclides in drinking water: the recent legislative requirements of the European Union.Radiation effects on soluble metabolites in cultured HeLa cells examined by 1H MRS: changes in concentration of glutathione and of lipid catabolites induced by gamma rays and proton beams.Summary of the Italian inter-society recommendations for radiation protection optimization in interventional radiology.(1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness.Optical imaging of dose distributions in Fricke gels.Radiation effects in cultured tumour cells examined by 1H MRS: mobile lipids modulation and proliferative arrest.Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs.Use of commercial alanine and TL dosemeters for dosimetry intercomparisons among Italian radiotherapy centresTDXAS study of the conformational landscape of MbCO
P50
Q36560256-001E8E6B-10A4-476A-8135-79E59EF9D33AQ38311800-212D1AED-96D4-42DC-8D63-D61CD6B18705Q38935921-8DF4EF63-FC8C-4EFB-B58B-9C3A5120E3C2Q39598559-A7D095FB-CB46-4693-8D57-086742FA31B4Q39673985-4DB95AC8-65DF-49C8-B7D4-EF36CB1DA42FQ39750570-1661EA7A-6B41-460B-9454-680CB1B51012Q39884998-E41E2705-F4B6-44EA-A4F6-9B303E84F752Q39971383-75D814F5-42FD-422E-9F92-3D7D474920EEQ40168145-9DD161BC-5770-4883-829C-F88FFB240B45Q40178392-60F82018-A227-4DFF-8119-6E0C3290F644Q40179471-D141AC4E-1A05-44B3-9831-1A528784736FQ40257678-09FD4699-308F-490E-B5BA-6912E43028DEQ40571889-2D2110E1-5FA1-4A0E-A7C6-5AAD1CC62924Q41716707-658107B6-3D79-4108-9051-180A599E8B40Q43981117-D2109B86-BDFC-4E37-9F48-5780EC685A1DQ47178887-E3C72461-1072-44A6-8F4F-1F8A948B2972Q48379304-77049B3A-8CAC-44CA-9281-77D0B4DBDA1CQ51226629-B3A3EFA8-4FC7-4A61-AFCC-D640663D64EFQ51926982-44F2A24E-FB10-49E2-AAE1-47DB765D3D63Q52659354-E0B00E97-8794-422A-A574-2D6D053312F3Q62725121-195EE7F2-841B-4300-8600-F18A84C32489Q62725128-3828F1CD-7363-4300-85FB-B6BEA1C1B6E3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sveva Grande
@ast
Sveva Grande
@en
Sveva Grande
@es
Sveva Grande
@nl
Sveva Grande
@sl
type
label
Sveva Grande
@ast
Sveva Grande
@en
Sveva Grande
@es
Sveva Grande
@nl
Sveva Grande
@sl
prefLabel
Sveva Grande
@ast
Sveva Grande
@en
Sveva Grande
@es
Sveva Grande
@nl
Sveva Grande
@sl
P1053
F-9363-2011
P106
P1153
16743520200
P21
P31
P3829
P496
0000-0002-1925-7602